LV11821B - Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours - Google Patents

Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours Download PDF

Info

Publication number: LV11821B
Authority: LV; Latvia
Prior art keywords: des; les; phosphate; une; use according
Prior art date: 1991-12-03

Application number

LVP-97-18A

Other languages

English (en)

Latvian (lv)

Other versions

LV11821A (lv

Inventor

Bru Nicole

Izrael Victor

Original Assignee

Bru Nicole

Izrael Victor

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-03

Filing date

1997-02-05

Publication date

1997-12-20

1997-02-05 Application filed by Bru Nicole, Izrael Victor filed Critical Bru Nicole

1997-08-20 Publication of LV11821A publication Critical patent/LV11821A/xx

1997-12-20 Publication of LV11821B publication Critical patent/LV11821B/lv

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LVP-97-18A 1991-12-03 1997-02-05 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours LV11821B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9114967A FR2684381B1 (fr)	1991-12-03	1991-12-03	Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active.
PCT/FR1992/001118 WO1993010792A1 (fr)	1991-12-03	1992-12-01	Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs

Publications (2)

Publication Number	Publication Date
LV11821A LV11821A (lv)	1997-08-20
LV11821B true LV11821B (en)	1997-12-20

Family

ID=9419629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-97-18A LV11821B (en)	1991-12-03	1997-02-05	Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours

Country Status (21)

Country	Link
US (1)	US5219846A (de)
EP (1)	EP0614366B1 (de)
JP (1)	JP3437574B2 (de)
KR (1)	KR100235893B1 (de)
AT (1)	ATE142499T1 (de)
AU (1)	AU3260093A (de)
BG (1)	BG61595B1 (de)
CA (1)	CA2124793C (de)
CZ (1)	CZ284966B6 (de)
DE (1)	DE69213757T2 (de)
DK (1)	DK0614366T3 (de)
ES (1)	ES2094522T3 (de)
FR (1)	FR2684381B1 (de)
GR (1)	GR3021876T3 (de)
HU (1)	HU216826B (de)
LV (1)	LV11821B (de)
RO (1)	RO115784B1 (de)
RU (1)	RU2097040C1 (de)
SK (1)	SK280785B6 (de)
UA (1)	UA41285C2 (de)
WO (1)	WO1993010792A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994016712A1 (en) *	1993-01-27	1994-08-04	Amira, Inc.	Creatine phosphate, creatine phosphate analogs, and uses therefor
AU6165894A (en) *	1993-01-28	1994-08-15	Trustees Of The University Of Pennsylvania, The	Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
US5714361A (en) *	1994-02-14	1998-02-03	Indiana University Foundation	Phosphatase/phosphodiesterase enzyme inhibitors and methods
US5627172A (en) *	1994-03-04	1997-05-06	Natural Supplement Association, Incorporated	Method for reduction of serum blood lipids or lipoprotein fraction
DE19537494C2 (de) *	1995-09-25	1997-10-02	Desitin Arzneimittel Gmbh	Kreatin zum Schutz von neuralem Gewebe
DE19653225A1 (de) *	1996-12-20	1998-06-25	Sueddeutsche Kalkstickstoff	Kreatin-pyruvate und Verfahren zu deren Herstellung
DE10116589A1 (de) *	2001-04-03	2002-10-10	Wulf Droege	Anwendung von Kreatin zur Minderung von oxidativem Stress
RU2309747C2 (ru) *	2002-09-18	2007-11-10	Михаил Владимирович Кутушов	Применение 2-хлорэтилфосфоновой кислоты и ее солей в качестве противоопухолевого средства
CA2525367A1 (en) *	2003-05-09	2004-11-25	The Trustees Of The University Of Pennsylvania	Use of citrate lyase inhibitors and tricarboxylate transporter inhibitors in the treatment of cancer
RU2354645C1 (ru) *	2007-11-21	2009-05-10	Закрытое Акционерное Общество "Вертекс"	Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
EP2269980A4 (de)	2008-12-24	2011-05-18	Vertex Closed Joint Stock Company	Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
RU2428414C2 (ru)	2009-11-03	2011-09-10	Закрытое Акционерное Общество "Вертекс"	Способ получения амидов креатина
WO2016007622A1 (en) *	2014-07-09	2016-01-14	Sidra Medical and Research Center	Imaging of creatine kinase enzyme expression in cancerous tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8200252L (sv) *	1982-01-18	1983-07-19	Pharmacia Ab	Farmaceutisk komposition
IT1214598B (it) *	1985-04-17	1990-01-18	Schiapparelli Farma	Uso terapeutico della fosfocreatina.
IT1191639B (it) *	1985-11-11	1988-03-23	Schiapparelli Farma	Composizione farmaceutica contenente fosfocreatina e metodo per preparla
US4874882A (en) *	1986-03-25	1989-10-17	Ube Industries, Ltd.	Process for preparing monosodium phosphoenolpyruvate
US4769318A (en) *	1986-06-03	1988-09-06	Ube Industries, Ltd.	Additive solution for blood preservation and activation

1991
- 1991-12-03 FR FR9114967A patent/FR2684381B1/fr not_active Expired - Lifetime
- 1991-12-20 US US07/811,058 patent/US5219846A/en not_active Expired - Lifetime
1992
- 1992-12-01 ES ES93901806T patent/ES2094522T3/es not_active Expired - Lifetime
- 1992-12-01 UA UA94005324A patent/UA41285C2/uk unknown
- 1992-12-01 AT AT93901806T patent/ATE142499T1/de active
- 1992-12-01 CA CA002124793A patent/CA2124793C/en not_active Expired - Fee Related
- 1992-12-01 HU HU9401656A patent/HU216826B/hu not_active IP Right Cessation
- 1992-12-01 AU AU32600/93A patent/AU3260093A/en not_active Abandoned
- 1992-12-01 SK SK683-94A patent/SK280785B6/sk not_active IP Right Cessation
- 1992-12-01 JP JP50989193A patent/JP3437574B2/ja not_active Expired - Fee Related
- 1992-12-01 RU RU9294030808A patent/RU2097040C1/ru not_active IP Right Cessation
- 1992-12-01 WO PCT/FR1992/001118 patent/WO1993010792A1/fr not_active Ceased
- 1992-12-01 DE DE69213757T patent/DE69213757T2/de not_active Expired - Lifetime
- 1992-12-01 DK DK93901806.5T patent/DK0614366T3/da active
- 1992-12-01 EP EP93901806A patent/EP0614366B1/de not_active Expired - Lifetime
- 1992-12-01 CZ CZ941343A patent/CZ284966B6/cs not_active IP Right Cessation
- 1992-12-01 RO RO94-00930A patent/RO115784B1/ro unknown
- 1992-12-01 KR KR1019940701870A patent/KR100235893B1/ko not_active Expired - Fee Related
1994
- 1994-06-01 BG BG98825A patent/BG61595B1/bg unknown
1996
- 1996-12-04 GR GR960403287T patent/GR3021876T3/el unknown
1997
- 1997-02-05 LV LVP-97-18A patent/LV11821B/lv unknown

Also Published As

Publication number	Publication date
CA2124793C (en)	2005-09-20
SK68394A3 (en)	1995-03-08
HUT68876A (en)	1995-08-28
CA2124793A1 (en)	1993-06-10
EP0614366B1 (de)	1996-09-11
HU216826B (hu)	1999-09-28
JP3437574B2 (ja)	2003-08-18
DE69213757T2 (de)	1997-04-03
WO1993010792A1 (fr)	1993-06-10
HU9401656D0 (en)	1994-09-28
FR2684381A1 (fr)	1993-06-04
DK0614366T3 (da)	1996-11-25
ES2094522T3 (es)	1997-01-16
RU94030808A (ru)	1996-10-20
CZ134394A3 (en)	1994-12-15
LV11821A (lv)	1997-08-20
GR3021876T3 (en)	1997-03-31
EP0614366A1 (de)	1994-09-14
DE69213757D1 (de)	1996-10-17
RU2097040C1 (ru)	1997-11-27
US5219846A (en)	1993-06-15
AU3260093A (en)	1993-06-28
FR2684381B1 (fr)	1995-05-05
CZ284966B6 (cs)	1999-04-14
BG98825A (bg)	1995-05-31
UA41285C2 (uk)	2001-09-17
JPH07501534A (ja)	1995-02-16
SK280785B6 (sk)	2000-07-11
RO115784B1 (ro)	2000-06-30
ATE142499T1 (de)	1996-09-15
BG61595B1 (bg)	1998-01-30
KR100235893B1 (ko)	1999-12-15

Similar Documents

Publication	Publication Date	Title
LV11821B (en)	1997-12-20	Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
US6506783B1 (en)	2003-01-14	Cancer treatments and pharmaceutical compositions therefor
Senter et al.	1989	Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates
SK99199A3 (en)	2000-05-16	Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator
EA026870B1 (ru)	2017-05-31	Комбинация и фармацевтическая композиция для лечения опухолей
SK87993A3 (en)	1993-12-08	Pharmaceutical composition
WO2004078781A1 (de)	2004-09-16	Protein-bindende doxorubicin-peptid-derivate
Molin	1987	Oral acyclovir prevents herpes simplex virus‐associated erythema multiforme
AU2002221622B2 (en)	2007-05-17	Antitumor therapy comprising distamycin derivatives
CN1296818A (zh)	2001-05-30	用于含癌的恶性新生物的抗恶性肿瘤剂
ES2278702T3 (es)	2007-08-16	Composicion para el tratamiento de metastasis o del cancer, que contiene fluorouracilo y un agente de transferencia de metilol.
EP3967310B1 (de)	2025-07-23	Zur weichgewebesarkomkombinationstherapie verwendetes chinolinderivat und epirubicin
JP4395368B2 (ja)	2010-01-06	細胞殺傷活性を有するカルシウム塩
ES2317913T3 (es)	2009-05-01	Tratamiento antitumoral combinado que comprende un derivado de la distamicina sustituida por acriloilo y un antimetabolito.
EP1372733B1 (de)	2012-10-03	Pharmazeutische zusammensetzungen von wirksamen polypeptiden zur verbesserung der pharmazeutischen wirksamkeit nach oraler oder parenteraler verabreichung
CN1422157A (zh)	2003-06-04	利用血管破坏活性的分割剂量疗法
JPH0378368B2 (de)	1991-12-13
DE68915289T2 (de)	1994-09-01	Neue antivirale mittel.
KR100844477B1 (ko)	2008-07-07	항종양 효과 증강제, 항종양제 및 암 치료 방법
JPH02215726A (ja)	1990-08-28	糖尿病治療剤
CN1110319C (zh)	2003-06-04	含蚯蚓纤溶酶的抗肿瘤药剂和保健品
JPH0667834B2 (ja)	1994-08-31	抗腫瘍剤
JP4382354B2 (ja)	2009-12-09	１−ブタン酸誘導体およびその使用
JPH0558892A (ja)	1993-03-09	発癌防止剤
JPWO2006132245A1 (ja)	2009-01-08	腫瘍増殖抑制剤